METAP2 and cervical carcinoma: In contrast to Metap2, Metap1-specific inhibition is relatively rarely investigated but was shown to have anti-tumor effects in cervical cancer and fibrosarcoma cells 65, as well as in human umbilical vein endothelial cells and human lung carcinoma cells 66.